Q2 2015 13F Holders as of 30 Jun 2015
-
Type / Class
-
Equity / COMMON STOCK
-
Shares outstanding
-
159M
-
Number of holders
-
87
-
Total 13F shares, excl. options
-
23.5M
-
Shares change
-
+1.11M
-
Total reported value, excl. options
-
$390M
-
Value change
-
+$18.8M
-
Put/Call ratio
-
0.74
-
Number of buys
-
58
-
Number of sells
-
-28
-
Price
-
$16.59
Significant Holders of TG THERAPEUTICS, INC. - COMMON STOCK (TGTX) as of Q2 2015
98 filings reported holding TGTX - TG THERAPEUTICS, INC. - COMMON STOCK as of Q2 2015.
TG THERAPEUTICS, INC. - COMMON STOCK (TGTX) has 87 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 23.5M shares
of 159M outstanding shares and own 14.8% of the company stock.
Largest 10 shareholders include FMR LLC (3.87M shares), RA CAPITAL MANAGEMENT, LLC (3.3M shares), STATE STREET CORP (2.09M shares), BAKER BROS. ADVISORS LP (2M shares), BRIDGER MANAGEMENT, LLC (1.54M shares), VANGUARD GROUP INC (1.1M shares), BlackRock Fund Advisors (930K shares), Sectoral Asset Management Inc (772K shares), BlackRock Institutional Trust Company, N.A. (743K shares), and Visium Asset Management, LP (530K shares).
This table shows the top 87 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.